NCT05996185 2026-04-14Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell LymphomaYale UniversityPhase 2 Recruiting22 enrolled
NCT05283720 2026-04-13A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin LymphomaGenmabPhase 2 Recruiting496 enrolled